We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients treated with onasemnogene abeparvovec recorded ...

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with ...

The least-squares mean difference in the Hammersmith Functional Motor Scale-Expanded change from baseline at 12 months was 1.8 points for those 2 to 12 years receiving apitegromab vs placebo.

Please provide your email address to receive an email when new articles are posted on . In TEMPO-1, fixed 5 mg and 15 mg doses of tavapadon improved outcomes in patients with Parkinson’s disease.

Scientists traced connectivity between neurons to identify how the brain communicates with the spinal cord to control motor function. Signals relayed to motor neurons from the brain enable muscle ...

A research team has revealed that a molecule in the brain -- ophthalmic acid -- unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic ...

A Swiss biotechnology firm has restored motor function in mice with Parkinson’s disease, paving the way for human trials later this year. In a presentation at the WORLDSymposium conference earlier ...

The movement-related benefits of Itvisma were maintained or continued to deepen over about 15 months after treatment, trial ...

Correspondence to Dr Iain Mayank Dutia, The University of Queensland School of Human Movement and Nutrition Sciences, Saint Lucia, QLD 4072, Australia; i.dutia{at}uq.edu.au Objective This study aims ...